Fetal Malnutrition
|
disease |
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
5
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Metaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
14
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Decreased waist to hip ratio
|
phenotype |
|
Finding
|
28
|
|
0.100 |
None |
|
0 |
|
|
|
Thyroid stimulating hormone measurement
|
phenotype |
|
Laboratory Procedure
|
42
|
83
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Chronic schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
48
|
7
|
0.310 |
None |
1.000 |
1 |
|
2013 |
2013 |
Fasting blood sugar result
|
phenotype |
|
Laboratory or Test Result
|
65
|
113
|
0.100 |
None |
1.000 |
2 |
2
|
2012 |
2012 |
peak expiratory flow (procedure)
|
phenotype |
|
Laboratory Procedure
|
74
|
119
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Glioblastoma, IDH-Wildtype
|
disease |
Neoplasms
|
Neoplastic Process
|
75
|
4
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Malignant neoplasm of stomach stage IV
|
disease |
|
Neoplastic Process
|
78
|
7
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Glucose measurement
|
phenotype |
|
Laboratory Procedure
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
elevated blood glucose level
|
phenotype |
|
Finding
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Fasting blood glucose measurement
|
phenotype |
|
Laboratory Procedure
|
96
|
212
|
0.100 |
None |
1.000 |
3 |
3
|
2012 |
2012 |
Soft Tissue Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
145
|
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Insulin Resistance
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
162
|
53
|
0.100 |
None |
|
0 |
|
|
|
Hypoxic-Ischemic Encephalopathy
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
182
|
12
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Pancreatic intraepithelial neoplasia
|
disease |
Neoplasms
|
Neoplastic Process
|
186
|
11
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
liposarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
200
|
6
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Prediabetes syndrome
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
205
|
16
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Carcinoma, Endometrioid
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
223
|
12
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Familial lichen amyloidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
230
|
24
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Eclampsia
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
241
|
38
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Platelet Count measurement
|
phenotype |
|
Laboratory Procedure
|
265
|
457
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Forced expiratory volume function
|
phenotype |
|
Organ or Tissue Function
|
272
|
1169
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Vital capacity
|
phenotype |
|
Clinical Attribute
|
430
|
746
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Gallbladder Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
498
|
75
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |